U.S. Communications Stock News

NYSE:ICL
NYSE:ICLChemicals

ICL Group (NYSE:ICL) Net Margin At 5.2% Tests Valuation Narratives Ahead Of Results

ICL Group (NYSE:ICL) has posted another steady quarter, with Q3 FY 2025 revenue of US$1.9 billion and basic EPS of US$0.09, supported by net income of US$115 million. Over the past few quarters, the company has seen revenue move from US$1.6 billion in Q4 FY 2024 to US$1.8 billion in Q2 FY 2025 and US$1.9 billion in Q3 FY 2025. Quarterly EPS has ranged between US$0.05 and US$0.09, setting up a results season in which investors are likely to focus closely on how resilient margins look from...
NasdaqGM:PRE
NasdaqGM:PREHealthcare

Prenetics Global (PRE) Quarterly Loss Narrows To US$5.5 Million Challenging Bearish Narratives

Prenetics Global (NasdaqGM:PRE) has just posted its FY 2025 third quarter numbers, with revenue of US$23.6 million and a basic EPS loss of US$0.40, keeping the company in loss-making territory. The company’s quarterly revenue has moved from US$10.5 million in Q4 2024 to US$17.3 million in Q1 2025, US$15.0 million in Q2 2025 and now US$23.6 million in Q3 2025. Over the same period, EPS losses have shifted from US$1.28 to US$0.80, US$0.64 and US$0.40. Investors are likely to weigh these results...
NYSE:MDT
NYSE:MDTMedical Equipment

Assessing Medtronic’s Valuation After Q3 2026 Beat And Ongoing Robotics And Cardiovascular Momentum

Medtronic (MDT) just released its Q3 2026 results, reporting revenue ahead of expectations and solid contributions from its cardiovascular and diabetes businesses. Management also reaffirmed full year guidance, even as costs and tariffs remain a headwind. See our latest analysis for Medtronic. Medtronic’s share price has been choppy in recent months, with a 2.16% 1 day share price gain after the Q3 release, but only a 1.79% 30 day share price return and a 0.87% 90 day share price decline. Its...
NYSE:HUN
NYSE:HUNChemicals

Huntsman (HUN) Loss-Making Quarter Extends Profitability Debate For Bulls And Bears

Huntsman (HUN) closed FY 2025 with fourth quarter revenue of US$1,355 million and a basic EPS loss of US$0.51, as the business continued to operate in the red on a trailing 12 month basis with EPS at a loss of US$1.59. Over the past six reported quarters, revenue has ranged between US$1,355 million and US$1,540 million, while basic EPS has stayed negative in every period. This highlights how top line stability has not yet translated into earnings stability. With analysts focused on a...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

Wall Street Backs EquipmentShare IPO Story With Growth And Valuation Upside

Wall Street brokerages have started coverage of EquipmentShare.com after its recent IPO, focusing on the company’s technology driven rental model. Analysts are highlighting EquipmentShare’s plans to expand its rental footprint and its capital light approach to fleet growth. The new coverage is drawing attention to the company’s goal of doubling rental locations and its position in the equipment rental industry. EquipmentShare.com, listed on NasdaqGS:EQPT, is coming onto more investors’...
NYSE:RVTY
NYSE:RVTYLife Sciences

Is Revvity (RVTY) Now Offering Value After Recent Share Price Weakness

If you are wondering whether Revvity at around US$97.74 is offering good value or just fair value, you are in the right place to unpack what the market might be pricing in. The stock has seen a 3.3% decline over the last 7 days, 13.1% over the last 30 days, and sits around a 0.4% year to date decline and a 14.8% decline over the past year. These moves can change how investors think about its growth potential and risk. Recent coverage of Revvity has focused on its role in the pharmaceuticals...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA (IQV) EPS Surge To US$3.02 Tests Bearish Margin Concerns

IQVIA Holdings (IQV) just closed out FY 2025 with Q4 revenue of US$4.4b and basic EPS of US$3.02, capping a year in which trailing 12 month revenue came in at US$16.3b and EPS reached US$7.91. Over the past few quarters, the company has seen revenue move from US$3.8b in Q1 2025 to US$4.1b in Q3 2025 and US$4.4b in Q4 2025. Quarterly EPS went from US$1.42 to US$1.94 to US$3.02, setting the stage for investors to weigh that earnings trajectory against an 8.3% net margin that sits below last...
NYSE:UAA
NYSE:UAALuxury

Why Under Armour (UAA) Is Up 12.6% After Deeper Loss Outlook And Final Curry 13 Launch

Under Armour reported past third-quarter 2025 results with sales of US$1,327.76 million and a net loss of US$430.83 million, and issued guidance for a full-year revenue decline of about 4% and a larger operating loss alongside no share repurchases in the latest quarter. At the same time, Under Armour marked the end of its long-running Stephen Curry partnership by launching the Curry 13, a final signature basketball shoe that underscores both the cultural impact of the collaboration and the...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Margin Compression Tests Bullish Silicon Carbide Growth Narrative

Axcelis Technologies (ACLS) just wrapped up FY 2025 with Q4 revenue of US$238.3 million and basic EPS of US$1.11, alongside trailing twelve month revenue of US$839.0 million and EPS of US$3.81 that frame the latest quarter in a fuller earnings picture. Over recent periods, the company has seen quarterly revenue range from US$192.6 million to US$238.3 million and quarterly EPS move between US$0.83 and US$1.11. During the same time, trailing twelve month revenue moved from US$958.1 million to...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Uptick And Ongoing Mixed Returns

Tandem Diabetes Care (TNDM) shares finished the latest session at US$18.94, drawing attention after a period of mixed returns, including negative moves over the past month, past 3 months, year, and longer horizons. See our latest analysis for Tandem Diabetes Care. That 0.5% 1 day share price gain to US$18.94 sits against a softer backdrop, with a 30 day share price return of 6.1% and a 1 year total shareholder return decline of 40.3%, which suggests recent momentum is still fading as...
NYSE:HPQ
NYSE:HPQTech

Is HPQ Share Weakness Creating A Potential Opportunity After Recent Tech Sector Reassessment?

If you are wondering whether HP's current share price reflects its underlying value, this article will walk you through what the numbers are really saying. HP shares, which last closed at US$18.35, have seen returns of 7.1% decline over 7 days, 9.9% decline over 30 days, and 17.0% decline year to date, contributing to a 44.7% decline over 1 year and 29.4% decline over 3 years, with a 22.2% decline over 5 years. Recent news coverage has focused on HP's position in the broader tech sector and...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart Reaches Trillion Dollar Milestone As Tech Focus And AI Deepen

Walmart (NasdaqGS:WMT) reached a $1 trillion market capitalization and marked the occasion with a relisting on the NASDAQ. The company appointed John Furner as CEO, highlighting a leadership shift as it leans further into technology centric retail. Walmart announced a partnership with OpenAI to bring ChatGPT powered shopping tools to its customers. For you as an investor, these moves signal how far Walmart has moved beyond its roots in big box retail into a broad commerce platform...
NYSE:EMR
NYSE:EMRElectrical

A Look At Emerson Electric (EMR) Valuation As Fresh Analyst Endorsements Draw New Attention

Why Emerson Electric’s new credit facility matters for shareholders Emerson Electric (EMR) has arranged a new US$2b 364 day credit facility that currently sits undrawn. This provides the company with added liquidity support while it continues to integrate past deals and address growth opportunities. See our latest analysis for Emerson Electric. Emerson’s new US$2b undrawn facility comes as the share price sits at US$151.14, with a 22.16% 90 day share price return and a 94.44% three year total...
NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCB) Net Interest Margin Gain Backs Bullish Profitability Narrative

United Community Banks (UCB) has wrapped up FY 2025 with fourth quarter revenue of US$264.7 million and basic EPS of US$0.71, supported by trailing twelve month revenue of US$1.0 billion and EPS of US$2.62. The bank has seen revenue move from US$901.2 million and EPS of US$2.04 over the prior trailing period to US$1.0 billion and EPS of US$2.62 most recently, alongside a net profit margin of 31.4% versus 27.1% a year earlier. This puts the focus firmly on how efficiently it is turning its top...
NYSE:OWL
NYSE:OWLCapital Markets

Blue Owl Capital (OWL) Valuation Check After Earnings Growth, Net Income Shift And Dividend Confirmation

Blue Owl Capital (OWL) shares were in focus after the company posted fourth quarter and full year 2025 results, and affirmed its regular dividend, a combination that can reset expectations around income and growth potential. See our latest analysis for Blue Owl Capital. Despite the earnings and dividend news lifting the 1 day share price return to 1.90%, Blue Owl Capital’s 30 day share price return of 22.72% and 1 year total shareholder return of 46.74% point to fading momentum after earlier...
NYSE:ELV
NYSE:ELVHealthcare

Assessing Elevance Health’s Valuation After Earnings Beat Outlook Upgrade And Large Share Buybacks

Elevance Health (ELV) is back in focus after another earnings beat, a higher outlook, and ongoing multibillion dollar share buybacks. This combination puts management decisions and capital return front and center for investors. See our latest analysis for Elevance Health. At a share price of US$346.24, Elevance Health has seen short term share price momentum pick up with a 7 day share price return of 3.0%. However, the 1 year total shareholder return of a 9.6% decline and 3 year total...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments By Law Shift Reframes Legal Risks And Valuation Context

Texas Instruments has amended its by laws to establish exclusive legal forums for certain corporate and securities related claims. The Delaware Court of Chancery is now the designated forum for many internal corporate disputes involving Texas Instruments. Federal courts are set as the exclusive venue for specific claims under US securities laws that apply to Texas Instruments and its shareholders. For investors in Texas Instruments, ticker NasdaqGS:TXN, this governance shift sits alongside...
NYSE:RHI
NYSE:RHIProfessional Services

How Investors May Respond To Robert Half (RHI) Elevating Marketing Leadership For AI-Enabled Growth Initiatives

Robert Half recently promoted Linda Christensen to senior vice president of global marketing, tasking her with leading global brand strategy, digital modernization and data-driven marketing to support the company’s long-term growth objectives. This leadership move, alongside the firm’s push into AI-enabled platforms and operational modernization, highlights how Robert Half is trying to sharpen its competitive edge in a challenging market. We’ll now examine how Christensen’s expanded remit...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Growth With MaxPeak Columns And Four-Division Realignment

Waters Corporation (NYSE:WAT) introduced new high-sensitivity liquid chromatography columns featuring MaxPeak Premier Technology. The company completed a realignment of its operations into four focused divisions aimed at adjacent high-growth markets. Waters, a long-established player in analytical instruments and laboratory solutions, is using this product launch and business realignment to sharpen its role in analytical sciences and diagnostics. The new columns with MaxPeak Premier...
NYSE:RYN
NYSE:RYNSpecialized REITs

Rayonier PotlatchDeltic Merger Reshapes Timberland Scale And Investor Outlook

Rayonier has closed its merger with PotlatchDeltic, forming a larger timberland REIT that will operate under the Rayonier name for now. The combined company significantly expands timberland holdings across key softwood regions in the U.S. and New Zealand. A new corporate name and ticker are expected later in the first quarter, while shares currently trade as NYSE:RYN at $23.5. For you as an investor, this merger shifts Rayonier, NYSE:RYN, into a different league in terms of size and...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

Assessing DocuSign (DOCU) Valuation As Goldman Sachs Flags Rising AI Automation Risk

AI concerns put DocuSign in focus Goldman Sachs’ new AI themed pair trade has put DocuSign (DOCU) under the microscope, after the firm tagged the e-signature provider as potentially exposed to automation risk on the short side. For investors, that classification raises fresh questions about how DocuSign’s US$3.2b revenue business, built around electronic signatures and broader agreement management tools, might be valued if markets increasingly separate perceived AI beneficiaries from...
NYSE:LLY
NYSE:LLYPharmaceuticals

Assessing Eli Lilly (LLY) Valuation After Recent Share Price Pullback

Assessing Eli Lilly after recent performance Eli Lilly (LLY) has drawn attention after a recent share price pullback, with the stock down about 2% over the past month and 2% over the past 3 months, prompting fresh questions on valuation. See our latest analysis for Eli Lilly. The recent pullback sits within a mixed picture, with a 1-day share price return of a 1.5% decline and a year-to-date share price return of a 5.5% decline. Meanwhile, the 1-year total shareholder return is 18.6% and the...
NYSE:QUAD
NYSE:QUADCommercial Services

Quad Graphics (QUAD) Return To Profitability Tests Bullish Margin Expansion Narrative

Quad/Graphics (QUAD) closed out FY 2025 with fourth quarter revenue of $630.6 million and basic EPS of $0.23, alongside net income of $11.1 million. Over the past few quarters, the company has seen revenue move from $708.4 million and EPS of $0.10 in Q4 2024 through $629.4 million and $0.12 in Q1 2025, $571.9 million and roughly breakeven EPS in Q2 2025, then $588 million and $0.21 in Q3 2025. This frames a year where profitability settled in at a trailing twelve month EPS of $0.57 on $2.4...